These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 13370465)

  • 1. [Independent hypoprothrombinemic action of anticoagulants derived from 4-hydroxycoumarin].
    DERECHIN M
    Prensa Med Argent; 1956 May; 43(20):1644. PubMed ID: 13370465
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of 4-hydroxycoumarin anticoagulant no. 63.
    ROTTER R; MEYER OO
    J Lab Clin Med; 1950 Dec; 36(6):981-2. PubMed ID: 14795070
    [No Abstract]   [Full Text] [Related]  

  • 3. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
    REILLY EB; GOODMAN JR; WARNER GF
    Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of 4 hydroxycoumarin anticoagulant No. 63 upon the prothrombin time in dogs and human beings.
    BATTLE WD; CAPPS RT
    J Lab Clin Med; 1950 Jan; 35(1):8-15. PubMed ID: 15400618
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticoagulant 3-(1-phenyl-propyl)-4-hydroxycoumarin in the treatment of phlebothrombosis and thrombophlebitis].
    PERCESEPE E
    Rass Int Clin Ter; 1956 Jul; 36(14):419-24. PubMed ID: 13379678
    [No Abstract]   [Full Text] [Related]  

  • 6. [Derivative of 4-hydroxycoumarin as a new anticoagulant].
    KLOSA J
    Pharmazie; 1954 Aug; 9(8):622. PubMed ID: 13224346
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ambulatory anticoagulant therapy with 3-(l-phenylpropyl)-4-hydroxycoumarin].
    KNOBEL P
    Praxis; 1956 Jan; 45(4):65-72. PubMed ID: 13310434
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experiences with 4-hydroxycoumarin anticoagulant No. 63 and the antagonistic effect of menadione and vitamin K.
    HANSON HH; BARKER NW; MANN FD
    Circulation; 1951 Dec; 4(6):844-63. PubMed ID: 14879492
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticoagulant properties and therapeutic use of a new coumarin derivative: 3-[2-acetyl-1-(p-nitrophenol)-ethyl]-4-hydroxycoumarin or coumarin G 23350].
    LEROUX M; JAMAIN B
    Therapie; 1956; 11(1):85-101. PubMed ID: 13337762
    [No Abstract]   [Full Text] [Related]  

  • 10. New anticoagulant for oral use-3-(1'-phenylpropyl)-4 hydroxycoumarin (liquamar); its evaluation for short-term therapy.
    GOLD H; LILLEY GW
    J Am Med Assoc; 1959 Jul; 170(11):1303-6. PubMed ID: 13664522
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical data on anticoagulant treatment with 3-(1-phenylpropy1)-4-hydroxycoumarin].
    VERGANI G
    Gazz Med Ital; 1955 Dec; 114(12):269-73. PubMed ID: 13305779
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new anticoagulant: 3-(1-phenylpropyl)4-hydroxycoumarin; early clinical results].
    VAN WIEN A; VEROFT R
    Acta Clin Belg; 1953; 8(6):618-28. PubMed ID: 13137838
    [No Abstract]   [Full Text] [Related]  

  • 13. [A new assymetrical vitamin K antagonist: 3-(alpha-naphthyl)-4-hydroxycoumarin].
    MORAUX J; MEUNIER P; MENTZER C
    Arch Int Pharmacodyn Ther; 1953 May; 94(1):47-64. PubMed ID: 13066148
    [No Abstract]   [Full Text] [Related]  

  • 14. Marcumar [3-(1'-phenylpropyl)-4-hydroxycoumarin]; a new anticoagulant.
    BOURGAIN R; TODD M; HERZIG L; WRIGHT IS
    Circulation; 1954 Nov; 10(5):680-4. PubMed ID: 13209748
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the anticoagulant action of 3-(alpha-p-chlorphenyl-beta-acetylethyl)-4-hydroxycoumarin (coumachlor) and dicoumarol in chicks and rats.
    DAM H; SØNDERGAARD E
    Acta Pharmacol Toxicol (Copenh); 1953; 9(2):137-47. PubMed ID: 13079850
    [No Abstract]   [Full Text] [Related]  

  • 16. Bishydroxycoumarin, ethyl biscoumacetate, and 4-hydroxycoumarin anticoagulant No. 63; comparative effects.
    BARKER NW; HANSON HH; MANN FD
    J Am Med Assoc; 1952 Jan; 148(4):274-7. PubMed ID: 14888460
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of acenocoumarin, a new 4-hydroxycoumarin anticoagulant.
    SCHILLING FJ; KRUESI OR
    Am J Med Sci; 1956 May; 231(5):558-63. PubMed ID: 13313541
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives.
    Abdelhafez OM; Amin KM; Batran RZ; Maher TJ; Nada SA; Sethumadhavan S
    Bioorg Med Chem; 2010 May; 18(10):3371-8. PubMed ID: 20435480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent hypoprothrombinaemia due to poisoning with a dicumarol-containing rat-killer.
    NILSSON IM
    Acta Haematol; 1957 Mar; 17(3):176-82. PubMed ID: 13410513
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation of 4-hydroxycoumarin anticoagulant No. 63.
    ROTTER R; MEYER OO
    AMA Arch Intern Med; 1951 Sep; 88(3):296-309. PubMed ID: 14856458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.